Cargando…
581. The Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit and Carbapenem Use
BACKGROUND: Acinetobacter baumannii (AB) infections cause high mortality and morbidity in intensive care unit patients. There are limited data on the epidemiology of imipenem-resistant A. baumannii (IRAB) amongst pediatric ICU patients. METHODS: A retrospective chart review was performed in patients...
Autores principales: | Kim, Dongsub, Lee, Haejeong, Croney, Christina M, Sup Park, Ki, Jung Park, Hyo, Cho, Joongbum, Soo Ko, Kwan, Kim, Jinyeong, Son, Sohee, Choi, Joon-sik, Choi, Soo-Han, Huh, Heejae, Ryeon Chung, Doo, Yong Lee, Nam, Kim, Yae-Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810977/ http://dx.doi.org/10.1093/ofid/ofz360.650 |
Ejemplares similares
-
The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 Years
por: Kim, Dongsub, et al.
Publicado: (2022) -
Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
por: Choi, Jun Yong, et al.
Publicado: (2006) -
Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002–2013
por: Kim, Young Ah, et al.
Publicado: (2018) -
1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022) -
Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Son, Hyo-Ju, et al.
Publicado: (2020)